HARBOUR INVESTMENTS, INC.

Position in CLLS — Cellectis S.A.

CIK 810121 MADISON, WI

Position in CLLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,265

-$7,515 QoQ

Shares Held

4,500

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HARBOUR INVESTMENTS, INC. holds $3,336,084 across 121 Biotechnology names. CLLS ranks #25 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	17,230	$560,664
2	REGN	Regeneron Pharmaceuticals, Inc.	640	$494,489
3	VRTX	Vertex Pharmaceuticals Inc / Ma	888	$396,527
4	JAZZ	Jazz Pharmaceuticals plc	1,384	$261,645
5	OMER	Omeros Corp	22,025	$232,584
6	CRSP	CRISPR Therapeutics AG	3,489	$165,971
7	CELC	Celcuity Inc.	1,000	$114,140
8	STOK	Stoke Therapeutics, Inc.	3,352	$109,141

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,265	4,500	0.0%	Shares	Sole	2026-05-15
2025-12-31	$21,780	4,500	0.0%	Shares	Sole	2026-02-09
2025-09-30	$12,825	4,500	0.0%	Shares	Sole	2025-11-12
2025-06-30	$6,862	4,500	0.0%	Shares	Sole	2025-07-28
2025-03-31	$5,580	4,500	0.0%	Shares	Sole	2025-05-08
2024-12-31	$8,100	4,500	-26.2%	Shares	Sole	2025-02-10
2024-09-30	$12,932	6,100	0.0%	Shares	Sole	2024-11-04
2024-06-30	$11,407	6,100	0.0%	Shares	Sole	2024-07-26
2024-03-31	$16,165	6,100	+270.6%	Shares	Sole	2024-07-22
2021-09-30	$20,756	1,646	+29.9%	Shares	Sole	2021-11-15
2021-06-30	$19,600	1,267	-38.1%	Shares	Sole	2021-08-16
2021-03-31	$41,390	2,048	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.